Condition: HIV-1-infection · Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
This study is being done to see if people who control HIV without antiretroviral therapy (ART) after receiving an intervention can remain off ART safely. The information collected in this study is also being used to try to understand how people control HIV without ART after receiving an intervention.
This description comes directly from the study's public registry record.
ACTG ClinicalTrials.gov Coordinator · (301)628-3348 · ACTGCT.gov@dlhcorp.com
Always discuss trial participation with your own doctor first.
| University of California, San Francisco HIV/AIDS CRS (801) | San Francisco, California, United States | Recruiting |
| Washington University Therapeutics (WT) CRS (2101) | St Louis, Missouri, United States | Recruiting |
| Weill Cornell Upton CRS (7803) | New York, New York, United States | Recruiting |
| Case CRS (2501) | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05985642